Clinical trial · Interventional
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
Evaluation of Dual Energy CT for the Detection of Gastrointestinal Carcinoids
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoid Syndrome | — | UNRESOLVED | — |
| Carcinoid Tumor | Neuroendocrine Tumor | ALIAS | 0.90 |
| Digestive System Neuroendocrine Tumor G1 | Digestive System Neuroendocrine Tumor G1 | ONTOLOGY_EXACT | 0.98 |
| Metastatic Carcinoid Tumor | Neuroendocrine Tumor | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dual-Energy Computed Tomography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Diagnostic (dual energy CT scan)
- description
- Patients undergo one dual energy CT scan during scheduled CT scan.
- interventionNames
- Procedure: Dual-Energy Computed Tomography
Primary outcomes (1)
- measure
- Sensitivity and specificity of dual energy computed tomography in detecting primary gastrointestinal carcinoid tumors
- timeFrame
- through study completion, an average of 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with: clinical features of carcinoid syndrome (or) increased serum and urinary markers suggestive of carcinoid (or) endoscopic biopsy proven carcinoid (or) metastases which are biopsy proven as carcinoid. * Patient is scheduled to have a clinically indicated staging CT exam. * Patients who have signed their informed consent form to undergo the study. Exclusion Criteria: * Patients who have already had their primary GI carcinoid resected. * Contraindication to intravenous contrast agents (e.g. allergy, renal failure, dialysis, pregnancy etc.). * Pregnant patients.
References
Publications (0)
Data not yet available